Jonathan Alspaugh Biography and Net Worth

Jonathan Alspaugh has over a decade of experience advising healthcare companies on strategic and financial matters. Jonathan joined Aeglea from Evercore where he most recently served as a managing director in the firm’s corporate advisory business. At Evercore, Jonathan was involved in numerous strategic transactions including advising Bristol-Myers Squibb on its acquisition of Celgene, Akebia on its merger with Keryx, PTC Therapeutics on its acquisition of Emflaza, and dozens of successful equity financings to support the strategic growth of clients in the biopharma space. Prior to Evercore, Jonathan was a member of Barclays Capital’s global healthcare investment banking team. Previously, Jonathan served in the United States Marine Corps infantry. Jonathan received an S.M. from the Harvard-MIT Division of Health Sciences and Technology, an M.B.A. from the Massachusetts Institute of Technology Sloan School of Management and a B.S.E. and an M.S.E. in Nuclear Engineering and Radiological Sciences from the University of Michigan.